Webinar of the “Silent Symptoms” Trial — Including Our Journey from COVID to MS

Cytokind, announces the release of its webinar on May 18th entitled Solving the Latitude Gradient in MS | Introducing the UV-B Kind Trial.  The webinar is hosted by Ahmed Obeidat, MD, PhD, from the Medical College of Wisconsin and Principal Investigator for the trial. He will introduce us to the history, motivations, and the scientists advancing this hybrid approach of @home phototherapy and its digital companion app.

In addition to Dr. Obeidat, the webinar will also feature:

  • Dr. Richard Weller of the University of Edinburgh, who will discuss The History, Benefits, & Risks of UV Light & Phototherapy
  • Dr. Prue Hart of the Telethon Kids Institute of the University of Western Australia, who will present A Summary of Phototherapy Trials for Multiple Sclerosis
  • Dr. Carmen Castilla, the Deputy Investigator of the UV-B Kind Trial, who will provide The History of Cytokind & The UV-B Kind Trial for Multiple Sclerosis
  • Kathy Reagan Young: a popular podcaster, MS patient advocate and an MS patient herself, who will discuss The Cytokind Companion App From the Patients’ Perspective

Cytokind’s webinar has been endorsed by the Consortium of Multiple Sclerosis Centers, the preeminent organization of Multiple Sclerosis health care professionals whose goal is to improve the lives of those affected by multiple sclerosis.

Cytokind will be at BOOTH #202 during the CSMC conference in Aurora, Colorado, May 31 – June 3.